Literature DB >> 36032613

Lower Limb Paralysis as Initial Presentation of Arterial Embolism Secondary to Heparin-Induced Thrombocytopenia after Hip Fracture - a Case Report.

Petros Kapsetakis1, Georgios Magarakis1, Constantinos Chaniotakis1, Phaedon D Zavras2, Georgios Kavalaris3, Christos Koutserimpas4, Kalliopi Alpantaki1.   

Abstract

Introduction: Prophylactic anticoagulation (AC) with low molecular weight heparins (LMWHs) following hip fracture has reduced the incidence of severe thromboembolic events. However, heparin-induced thrombocytopenia (HIT) remains a serious complication in these patients. Clinical case: We report an unusual case of thrombosis due to severe HIT in a 75-year-old female patient following intramedullary nailing for a hip fracture. The patient was taking Verapamine. On the fourth postoperative day she developed paralysis, paresthesia and mild pain over the right lower extremity; faint pulses were palpated. Computed tomography angiogram identified superficial artery occlusion leading to limb ischemia. Anti-platelet factor 4 (PF4) heparin antibody positivity confirmed the diagnosis of HIT. Urgent embolectomy was performed and the patient achieved full recovery. Discussion: Arterial embolism presenting with severe neurological deficits is a rare complication of HIT.
Conclusion: A high index of suspicion and close platelet count monitoring is warranted for early diagnosis and treatment of this devastating condition that can be limb and life threatening.

Entities:  

Year:  2022        PMID: 36032613      PMCID: PMC9375862          DOI: 10.26574/maedica.2022.17.2.513

Source DB:  PubMed          Journal:  Maedica (Bucur)        ISSN: 1841-9038


  17 in total

Review 1.  Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Lori-Ann Linkins; Antonio L Dans; Lisa K Moores; Robert Bona; Bruce L Davidson; Sam Schulman; Mark Crowther
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Can heparin-induced thrombocytopenia be associated with fondaparinux use? A rebuttal.

Authors:  I Elalamy; B Tribout
Journal:  J Thromb Haemost       Date:  2008-07       Impact factor: 5.824

3.  Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia.

Authors:  Theodore E Warkentin; Jo-Ann I Sheppard; Christopher S Sigouin; Thomas Kohlmann; Petra Eichler; Andreas Greinacher
Journal:  Blood       Date:  2006-07-20       Impact factor: 22.113

4.  Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis.

Authors:  Nadine Martel; James Lee; Philip S Wells
Journal:  Blood       Date:  2005-06-28       Impact factor: 22.113

Review 5.  Heparin induced thrombocytopenia: diagnosis and management update.

Authors:  I Ahmed; A Majeed; R Powell
Journal:  Postgrad Med J       Date:  2007-09       Impact factor: 2.401

6.  Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin.

Authors:  T E Warkentin; M N Levine; J Hirsh; P Horsewood; R S Roberts; M Gent; J G Kelton
Journal:  N Engl J Med       Date:  1995-05-18       Impact factor: 91.245

7.  Cost and occurrence of thrombocytopenia in patients receiving venous thromboembolism prophylaxis following major orthopaedic surgeries.

Authors:  Laura Elizabeth Happe; Eileen Marie Farrelly; Richard H Stanford; Matt William Sarnes
Journal:  J Thromb Thrombolysis       Date:  2007-11-24       Impact factor: 2.300

8.  Heparin-induced thrombocytopenia (HIT): Review of incidence, diagnosis, and management.

Authors:  Marie Hogan; Jeffrey S Berger
Journal:  Vasc Med       Date:  2020-03-20       Impact factor: 3.239

9.  Heparin-induced thrombocytopenia: temporal pattern of thrombocytopenia in relation to initial use or reexposure to heparin.

Authors:  Norbert Lubenow; Reiner Kempf; Angelika Eichner; Petra Eichler; Lena E Carlsson; Andreas Greinacher
Journal:  Chest       Date:  2002-07       Impact factor: 9.410

10.  Incidence and clinical relevance of heparin-induced antibodies in patients with deep vein thrombosis treated with unfractionated or low-molecular-weight heparin.

Authors:  Edelgard Lindhoff-Last; Roumen Nakov; Frank Misselwitz; Hans-Klaus Breddin; Rupert Bauersachs
Journal:  Br J Haematol       Date:  2002-09       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.